{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T03:40:20Z","timestamp":1719200420785},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,1]]},"DOI":"10.1093\/jjco\/hyx076","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T19:10:22Z","timestamp":1494616222000},"page":"820-825","source":"Crossref","is-referenced-by-count":3,"title":["Effective chemomobilization with etoposide and cytarabine (EC regimen) in lymphoma patients: a single-center, retrospective, observational study"],"prefix":"10.1093","volume":"47","author":[{"given":"Daisuke","family":"Koyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Nishiwaki","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Harada","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satomi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Kurahashi","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takumi","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Iwasaki","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isamu","family":"Sugiura","sequence":"additional","affiliation":[{"name":"Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,5,24]]},"reference":[{"key":"key\n\t\t\t\t2018111409054957300_hyx076C1","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone-marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C2","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/S0140-6736(02)08938-9","article-title":"Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial","volume":"359","author":"Schmitz","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/jjco\/hyu204","article-title":"Recent advances in Hodgkin lymphoma: interim PET and molecular-targeted therapy","volume":"45","author":"Nagai","year":"2015","journal-title":"Jpn J Clin Oncol"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C4","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1200\/JCO.1995.13.10.2547","article-title":"Factors that influence collection and engraftment of autologous peripheral-blood stem-cells","volume":"13","author":"Bensinger","year":"1995","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C5","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1182\/blood.V86.10.3961.bloodjournal86103961","article-title":"An analysis of engraftment kinetics as a function of the CD34 content of peripheral-blood progenitor-cell collections in 692 patients after the administration of myeloablative chemotherapy","volume":"86","author":"Weaver","year":"1995","journal-title":"Blood"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.bbmt.2008.07.004","article-title":"Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation","volume":"14","author":"Pusic","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.bmt.1703364","article-title":"Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma","volume":"29","author":"Pavone","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C8","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1200\/JCO.2010.28.1618","article-title":"Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era","volume":"28","author":"Gisselbrecht","year":"2010","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/10428199909083387","article-title":"Feasibility of ESHAP plus G-CSF as peripheral blood hematopoietic progenitor cell mobilisation regimen in resistant and relapsed lymphoma: a single-center study of 22 patients","volume":"34","author":"Petit","year":"1999","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1054\/bjoc.1999.0915","article-title":"ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients","volume":"82","author":"Watts","year":"2000","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/sj.bmt.1704798","article-title":"ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSF","volume":"35","author":"Lee","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C12","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF02986620","article-title":"Pilot phase I\/II study of new salvage therapy (CHASE) for refractory or relapsed malignant lymphoma","volume":"77","author":"Ogura","year":"2003","journal-title":"Int J Hematol"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1349-7006.2007.00662.x","article-title":"Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma","volume":"99","author":"Oki","year":"2008","journal-title":"Cancer Sci"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbmt.2013.10.013","article-title":"Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations","volume":"20","author":"Giralt","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C15","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/sj.bmt.1701791","article-title":"Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization","volume":"23","author":"Reiser","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C16","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/ejh.12266","article-title":"Chemomobilization with high-dose etoposide and G-CSF results in effective and safe stem cell collection in heavily pretreated lymphoma patients: report from a single institution study and review","volume":"92","author":"Ozkan","year":"2014","journal-title":"Eur J Haematol"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/trf.12906","article-title":"Intermediate doses of cytarabine plus granulocyte-colony-stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure","volume":"55","author":"Calder\u00f3n-Cabrera","year":"2015","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/scd.1.1994.3.3","article-title":"Automated enumeration of CD34+ cells in peripheral blood and bone marrow","volume":"3","author":"Chen","year":"1994","journal-title":"J Hematother"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.2517-6161.1958.tb00292.x","article-title":"The regression-analysis of binary sequences","volume":"20","author":"Cox","year":"1958","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C20","first-page":"341","article-title":"Collection of peripheral-blood stem-cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor","volume":"10","author":"Shimazaki","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C21","first-page":"763","article-title":"Mobilization of peripheral-blood progenitor cells by high-dose Ara-C, VP-16 and recombinant human granulocyte-colony-stimulating factor \u2013 factors affecting progenitor-cell yields","volume":"15","author":"Shimazaki","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"key\n\t\t\t\t2018111409054957300_hyx076C22","doi-asserted-by":"crossref","first-page":"986","DOI":"10.3109\/10428194.2010.551154","article-title":"Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma","volume":"52","author":"Hill","year":"2011","journal-title":"Leuk Lymphoma"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/47\/9\/820\/26567339\/hyx076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T03:01:57Z","timestamp":1719198117000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/47\/9\/820\/3852039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,24]]},"references-count":22,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,5,24]]},"published-print":{"date-parts":[[2017,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyx076","relation":{},"ISSN":["0368-2811","1465-3621"],"issn-type":[{"value":"0368-2811","type":"print"},{"value":"1465-3621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,9]]},"published":{"date-parts":[[2017,5,24]]}}}